Highlights From the Circulation Family of Journals
Circulation
JULY 21, 2024
Circulation, Volume 150, Issue 4 , Page 336-339, July 23, 2024.
Circulation Related Topics 
81 
Circulating microRNAs as biomarkers of Chagas cardiomyopathy
Frontiers in Cardiovascular Medicine
DECEMBER 18, 2023
Methods We carried out a case-control study to identify circulating miRNAs associated with CHCM. We performed a clinical, echocardiographic, and laboratory evaluation and profiled circulating miRNA in the serum samples. Results Differences between groups were observed in clinical variables and in the analysis of miRNAs.
Researchers identify circulating proteins linked to preeclampsia and other hypertensive disorders of pregnancy
Medical Xpress - Cardiology
JANUARY 3, 2024
Preeclampsia and other hypertensive disorders of pregnancy—which are characterized by high blood pressure with or without organ dysfunction during the second half of pregnancy—carry considerable short- and long-term risks for both the mother and child. Treatment options (other than expedited delivery) remain limited.
Circulating palmitoyl sphingomyelin levels predict the 10-year increased risk of cardiovascular disease death in Chinese adults: findings from the Da Qing Diabetes Study
Cardiovascular Diabetology
JANUARY 19, 2024
Whether circulating PSM levels. Higher levels of palmitoyl sphingomyelin (PSM, synonymous with sphingomyelin 16:0) are associated with an increased risk of cardiovascular disease (CVD) in people with diabetes.
Study Suggests COPD Preventative Measures Needed During Seasonal Virus Circulations
HCPLive
JUNE 7, 2024
These data indicate the benefits of implementing individual protective measures in winter by patients with COPD.
Circulating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular events
Medical Xpress - Cardiology
APRIL 15, 2024
An analysis of the biomolecule substudy of the EAST–AFNET 4 trial has revealed that biomolecule concentrations in the blood of patients with atrial fibrillation can be used to identify patients at high and low cardiovascular risk. The findings were published in Cardiovascular Research.
SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study
Cardiovascular Diabetology
MAY 6, 2024
Sodium-glucose cotransporter 2 (SGLT2) and SGLT1 inhibitors may have additional beneficial metabolic effects on circulating metabolites beyond glucose regulation, which could contribute to a reduction in the b.
Let's personalize your content